Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
<p>Abstract</p> <p>Background</p> <p>The development of a successful new tuberculosis (TB) vaccine would circumvent many limitations of current diagnostic and treatment practices. However, vaccine development is complex and costly. We aimed to assess the potential cost...
Saved in:
Main Authors: | Menzies Dick (Author), Oxlade Olivia (Author), Tseng Chia-Lin (Author), Aspler Anne (Author), Schwartzman Kevin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
by: Barr Graham, et al.
Published: (2006) -
Tuberculosis screening of travelers to higher-incidence countries: A cost-effectiveness analysis
by: Menzies Dick, et al.
Published: (2008) -
Putting numbers on the End TB Strategy-an impossible dream?
by: Olivia Oxlade, et al.
Published: (2016) -
Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
by: Mayara Lisboa Bastos, et al.
Published: (2022) -
Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis
by: Aashna Uppal, et al.
Published: (2021)